DE3750023T2 - Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat. - Google Patents

Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.

Info

Publication number
DE3750023T2
DE3750023T2 DE3750023T DE3750023T DE3750023T2 DE 3750023 T2 DE3750023 T2 DE 3750023T2 DE 3750023 T DE3750023 T DE 3750023T DE 3750023 T DE3750023 T DE 3750023T DE 3750023 T2 DE3750023 T2 DE 3750023T2
Authority
DE
Germany
Prior art keywords
imidazolyl
pentyl
methyl
preparation
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750023T
Other languages
English (en)
Other versions
DE3750023D1 (de
Inventor
Douglas John Meldrum Allen
William Michael Snyder
Berkeley Wendell Cue
Stanley Walter Walinsky
Paul David Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1986/002307 external-priority patent/WO1988003140A1/en
Priority claimed from PCT/US1986/002308 external-priority patent/WO1988003141A1/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE3750023D1 publication Critical patent/DE3750023D1/de
Application granted granted Critical
Publication of DE3750023T2 publication Critical patent/DE3750023T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/24—Derivatives of thiourea containing any of the groups, X being a hetero atom, Y being any atom
    • C07C335/28—Y being a hetero atom, e.g. thiobiuret

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE3750023T 1986-10-29 1987-10-16 Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat. Expired - Fee Related DE3750023T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1986/002307 WO1988003140A1 (en) 1986-10-29 1986-10-29 Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole dihydrochloride trihydrate
PCT/US1986/002308 WO1988003141A1 (en) 1986-10-29 1986-10-29 Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and analogs

Publications (2)

Publication Number Publication Date
DE3750023D1 DE3750023D1 (de) 1994-07-14
DE3750023T2 true DE3750023T2 (de) 1994-09-29

Family

ID=26774088

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750023T Expired - Fee Related DE3750023T2 (de) 1986-10-29 1987-10-16 Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.

Country Status (14)

Country Link
EP (1) EP0269239B1 (de)
KR (1) KR900002343B1 (de)
CN (1) CN1022567C (de)
AT (1) ATE106884T1 (de)
DE (1) DE3750023T2 (de)
DK (1) DK565187A (de)
EG (1) EG18271A (de)
ES (1) ES2054684T3 (de)
IE (1) IE872897L (de)
IL (1) IL84301A (de)
NZ (1) NZ222306A (de)
PL (1) PL149549B1 (de)
PT (1) PT86011B (de)
YU (1) YU46081B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002127A1 (en) * 1988-08-30 1990-03-08 Pfizer Inc. Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino-4-imidazolyl)thiazole
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
CN100384237C (zh) * 2004-02-28 2008-04-23 鸿富锦精密工业（深圳）有限公司 音量调整装置及方法
CN100517961C (zh) * 2004-04-03 2009-07-22 鸿富锦精密工业（深圳）有限公司 音量调整装置及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US391473A (en) * 1888-10-23 Feedeeick j
US3798269A (en) * 1968-08-05 1974-03-19 R Cutler Amidinoureas and amidinothioureas
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents

Also Published As

Publication number Publication date
CN87107492A (zh) 1988-05-11
KR900002343B1 (ko) 1990-04-12
KR880005124A (ko) 1988-06-28
PL268454A1 (en) 1988-09-01
ATE106884T1 (de) 1994-06-15
EP0269239B1 (de) 1994-06-08
ES2054684T3 (es) 1994-08-16
PT86011A (en) 1987-11-01
DE3750023D1 (de) 1994-07-14
DK565187A (da) 1988-04-30
NZ222306A (en) 1989-09-27
EG18271A (en) 1992-12-30
CN1022567C (zh) 1993-10-27
YU195787A (en) 1988-12-31
YU46081B (sh) 1992-12-21
DK565187D0 (da) 1987-10-28
IE872897L (en) 1988-04-29
EP0269239A3 (en) 1990-03-28
PT86011B (pt) 1990-08-31
EP0269239A2 (de) 1988-06-01
IL84301A (en) 1992-08-18
PL149549B1 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
DE69126350D1 (de) Verfahren zur Herstellung von Chlorothiazolderivaten
DK478788D0 (da) Polymorf modifikation af forbindelsen 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro-(4.5) decan-7,9-dion
DE3750023T2 (de) Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.
DK147588A (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
ATE53034T1 (de) Verfahren zur herstellung von cephemverbindungen.
PT72421A (de) Verfahren zur herstellung von kristallinen salzen
ATE64392T1 (de) Thiazolidin-4-one-derivate un deren saeureadditionssalze.
ATE138376T1 (de) Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen
KR910011839A (ko) 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제
DK359589A (da) Fremgangsmaade til fremstilling af n-substituerede guanylthiourinstoffer
PT75981B (en) Process for the preparation of n,n-dissubstituted alkenamides and phenyl alkenamides
HUT49845A (en) Process for producing optically active n-substituted alanine derivatives with herbicidal effect

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee